封面
市場調查報告書
商品編碼
1736738

全球骨內裝置市場:市場規模(按類型、最終用戶和地區分類)、未來預測

Global Intraosseous Devices Market Size By Type (Manual, Semi-Automatic, Automatic), By End-User (Hospitals, Emergency Medical Services (EMS), Military), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

骨內器械的市場規模和預測

2024 年骨內設備市場規模價值 4.1282 億美元,預計到 2032 年將達到 5.9294 億美元,2026 年至 2032 年的複合年成長率為 4.63%。

心臟麻痹等各種疾病的高發病率、包括創傷在內的緊急情況以及日益增多的軍事介入預計將推動全球骨內器械市場的成長。越來越多的政府和監管機構的核准是骨內器械市場的基礎。此外,研發活動的活性化和公眾健康意識的增強也推動著市場的成長。本報告對全球骨內器材市場進行了全面的評估,全面分析了關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及影響市場的關鍵因素。

定義全球骨內設備市場

骨內裝置是用來處理危及生命狀況的緊急醫療設備。在無法建立靜脈通路的緊急情況下,骨內裝置用於輸送藥物和重要液體。骨內血管是緊急情況下即時醫療介入的替代方案。此裝置可快速插入骨髓腔,並透過靜脈輸液流入裝置來指示裝置的準確位置。

如果液體滲出到插入部位周圍,則應移除裝置以防止腔室症候群的擴散。然而,骨髓穿刺是另一種確認裝置正確放置的方法。骨內裝置快速、簡單且有效。它們透過骨髓將藥物直接注入體循環,在緊急或延誤的情況下非常有用。這些裝置用於治療血液科/腫瘤科患者、創傷、心臟麻痹和糖尿病患者。

全球骨內器材市場概況

預計近期損傷發生率的上升以及靜脈血管通路的失效將推動骨內器械市場的發展。當其他給藥途徑無法達到預期效果時,骨內輸注是一種安全有效的心肺復甦術。

多種疾病(例如心臟麻痹)的高發病率、創傷等緊急情況以及軍事介入的不斷增加,正在推動全球骨內器械市場的發展。人均收入的提高和對先進醫療保健的投資意願的增強也推動了需求的成長。腹腔內輸液最常用於兒科院前急救,因為在這種緊急情況下,靜脈注射是不可能的。多種疾病類型的盛行率上升以及創傷性手術的數量增加,可能會在未來幾年推動對這些器械的需求。

諸如插入過程中的骨折、給藥過程中的藥物洩漏以及插入部位感染疾病等風險,以及高昂的藥品成本、護理人員缺乏醫療專業知識以及設備管理不善等因素,都是骨內器械市場的潛在限制因素。日益增多的監管核准、併購以及新興經濟體創造的新市場,為市場帶來了豐厚的成長機會。

目錄

第1章全球骨內器械市場簡介

  • 市場概覽
  • 分析範圍
  • 先決條件

第2章執行摘要

第3章 已驗證的市場研究分析方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球骨內裝置市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球骨內裝置市場(按類型)

  • 概述
  • 手動的
  • 半自動
  • 自動的

6. 全球骨內裝置市場(依最終用戶)

  • 概述
  • 醫院
  • 緊急醫療服務(EMS)
  • 軍隊
  • 其他

7. 全球骨內裝置市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他地區 (ROW)
    • 拉丁美洲
    • 中東和非洲

8. 全球骨內裝置市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第9章 公司簡介

  • Teleflex Incorporated
  • PERSYS MEDICAL
  • Cook
  • BD
  • Biopsybell
  • Pyng Medical Corp.
  • Aero Healthcare
  • Vidacare Corporation
  • Carefusion Inc.

第10章 附錄

  • 相關分析
簡介目錄
Product Code: 40498

Intraosseous Devices Market Size And Forecast

Intraosseous Devices Market size was valued at USD 412.82 Million in 2024 and is projected to reach USD 592.94 Million by 2032, growing at a CAGR of 4.63% from 2026 to 2032.

The high prevalence of various diseases, such as cardiac arrest, emergencies including trauma, and increasing military engagements are expected to fuel the growth of the global Intraosseous Devices Market. Growth in the number of government and regulatory approvals is proving to be the foundation for the Intraosseous Devices Market. In addition, the increasing research and development activities as well as the increased awareness about public health is driving the market growth. The Global Intraosseous Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Intraosseous Devices Market Definition

Intraosseous devices are emergency medical equipment used for dealing with life-threatening conditions. Intraosseous devices can be used to supply medications and vital fluids in an emergency when venous access is absent. Intraosseous vascular is an alternative method for immediate medical intervention during emergency conditions. The device is quickly inserted into the medullary space of bone and accurate positioning of the device is indicated by the flow of intravenous fluid into the device.

If extravasation of the fluid around the insertion area occurs, the device is removed to prevent the growth of compartment syndrome. However, aspiration of bone marrow signifies another method to confirm the correct positioning of the device. Intraosseous devices are quick, easy, and effective. This device infuses medication directly into systemic circulation via bone marrow and is useful in emergency and delayed situations. These devices are used in the treatment of hematology/oncology patients, traumas, cardiac arrest, and diabetic patients.

Global Intraosseous Devices Market Overview

The increasing number of injuries, along with the failure of intravenous vascular access, is expected to fuel the market for intraosseous devices in the immediate future. Intraosseous infusion is a secure and efficient technology for cardiopulmonary resuscitation where other routes of administration struggle to achieve the desired impact.

The high prevalence of multiple diseases such as cardiac arrest, emergencies such as trauma, and rising military engagements are driving the global Intraosseous Devices Market. The increasing per capita income and a growing willingness to invest in advanced care are also fueling demand. Intraosseous infusion is most often used in pediatric pre-hospital emergencies where intravenous administration of fluids and medications is impossible. The rising prevalence of multiple disease types, as well as the number of traumatic surgeries, are likely to drive demand for these devices in the coming years.

The risks such as fractures during insertion, extravasation of drugs being managed, infections at the insertion site, as well as high medication costs, a shortage of medical expertise for nurses, and poor equipment management, are potential factors restraining the Intraosseous Devices Market. The rising regulatory approvals, mergers and acquisitions, and new markets created by developing economies present favorable growth opportunities in the market.

Global Intraosseous Devices Market Segmentation Analysis

The Global Intraosseous Devices Market is Segmented on the basis of Type, End-User, And Geography.

Intraosseous Devices Market, By Type

  • Manual
  • Semi-Automatic
  • Automatic

Based on Type, The market is segmented into Manual, Semi-Automatic, and Automatic. The automatic and semi-automatic segments are projected to grow because they are more technologically advanced than the manual.

Intraosseous Devices Market, By End-User

  • Hospitals
  • Emergency Medical Services (EMS)
  • Military
  • Others

Based on End-User, The market is segmented into Hospitals, Emergency Medical Services (EMS), Military, and Others. Due to the increased number of emergency situations, expanding medical personnel and specialized personnel, and growing patient population cases, the EMS segment is projected to lead the global Intraosseous Devices Market.

Intraosseous Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Intraosseous Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the strongest market share and is expected to grow in the coming years. The demand in North America is primarily led by an increase in the number of emergency cases, cardiac cases, and multiple diseases requiring immediate vascular access, as well as an increase in the acceptance of advanced products, a large number of medical practitioners, and specialized personnel, and the involvement of prominent players in these regions.

Key Players

The "Global Intraosseous Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, Biopsybell, Pyng Medical Corp., Aero Healthcare, Vidacare Corporation, Carefusion Inc., and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Mergers and Acquisitions
  • In December 2013, Teleflex Incorporated acquired Vidacare Corporation, a provider of intraosseous, or into the bone, access devices. This acquisition complemented the vascular access and specialty product portfolio of the company's critical care product group.
  • Product Launches and Product Expansions
  • In March 2020, SAM Medical launched SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
  • In November 2019, Piper Access, LLC received FDA 510(k) clearance for Piper Go-IO Intraosseous Infusion System from Piper Access.
  • In May 2018, TraumaFX, a division of Kforce Government Solutions, Inc. and a global provider of ruggedized human and canine medical training simulators, launched K9 Diesel, a canine medical simulator.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRAOSSEOUS DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL INTRAOSSEOUS DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.2 Porters Five Force Model
  • 4.3 Value Chain Analysis

5 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Manual
  • 5.3 Semi-Automatic
  • 5.4 Automatic

6 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Emergency Medical Services (EMS)
  • 6.4 Military
  • 6.5 Others

7 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL INTRAOSSEOUS DEVICES MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Teleflex Incorporated
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 PERSYS MEDICAL
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Cook
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 BD
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Biopsybell
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Pyng Medical Corp.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Aero Healthcare
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Vidacare Corporation
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Carefusion Inc.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments

10 APPENDIX

  • 10.1 Related Research